海西新药HX9428片启动Ⅰ期临床 适应症为湿性年龄相关性黄斑变性

新浪财经
Jan 21

药物临床试验登记与信息公示平台数据显示,福建海西新药创制股份有限公司的HX9428片在健康试验参与者中单中心、随机、开放、两周期、两序列、双交叉、单次空腹/餐后给药食物影响研究已启动。临床试验登记号为CTR20260189,首次公示信息日期为2026年01月21日。该药物剂型为片剂,规格20mg,用法用量为按试验方案空腹/在开始进餐后30 min时口服,单次给药,每次1片,每周期1次,共给药2周期...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10